Milk-alkali syndrome: A historical review and description of the modern version of the syndrome

American Journal of the Medical Sciences

Volumn 331, Issue 5, 2006, Pages 233-242

  Beall, Douglas P ^a,b   Henslee, Heidi B ^a   Webb, Heather R ^a   Scofield, R Hal ^a,b,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Calcium carbonate; Hypercalcemia; Milk alkali syndrome; Parathyroid hormone

Indexed keywords

CALCIUM CARBONATE; NON PRESCRIPTION DRUG;

ADULT; AGED; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; FOOD DRUG INTERACTION; HISTORY OF MEDICINE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MILK; MILK ALKALI SYNDROME; PARATHYROID HORMONE BLOOD LEVEL; PATHOPHYSIOLOGY; PEPTIC ULCER; REVIEW; SYSTEMATIC REVIEW;

CALCIUM CARBONATE; DRUGS, NON-PRESCRIPTION; HUMANS; HYPERCALCEMIA; MILK HYPERSENSITIVITY; PARATHYROID HORMONE;

EID: 33744485270     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200605000-00001     Document Type: Review

References (116)

1. Sippy BW. Gastric and duodenal ulcer: medical cure by an efficient removal of gastric juice corrosion. JAMA 1915;64:1625-30.
2. Hardt LL, Rivers AB. Toxic manifestations following the alkaline treatment of peptic ulcer. Arch Intern Med 1923;31:171-80.
3. Cope CL. Base changes in the alkalosis produced by the treatment of gastric ulcer with alkalies. Clin Sci 1936;2:287-300.
4. Burnett CH, Commons RR, Albright F, et al. Hypercalcemia without hypercalciuria or hyperphosphatemia, calcinosis and renal insufficiency: a syndrome following the prolonged intake of milk and alkali. N Engl J Med 1949;240:786-94.
5. Kessler E. Hypercalcemia and renal insufficiency secondary to excessive milk and alkali intake. Ann Intern Med 1955;422:324-38.
6. Dworelzky M. Reversible metastatic calcification (milk drinkers syndrome). JAMA 1954;155:830-32.
7. Snapper I, Bradley WG, Wilson VE. Metastatic calcification and nephrocalcinosis from medical treatment of peptic ulcer. Arch Intern Med 1954;93:807-17.
8. Werner P, Kuschner M, Riley EA. Reversible metastatic calcification associated with excessive milk and alkali intake. Am J Med 1953;14:108-15.
9. Dufault FX, Toblas GJ. Potentially reversible renal failure following excessive calcium and alkali intake in peptic ulcer therapy. Am J Med 1954;16:231-36.
10. Rodman G, Johnson H. Chronic renal failure in association with the excessive intake of calcium and alkali: report of a case and review of pathogenesis. Gastroenterol 1954;27:585-97.
11. Miller JM, Freeman I, Heath WH. Calcinosis due to treatment of duodenal ulcer. JAMA 1952;148:198-99.
12. Punsar S, Somer T. The milk-alkali syndrome: a report of three illustrative cases and a review of the literature. Acta Med Scand 1962;173:435-49.
13. Wenger J, Kersner JB, Palmer WL. The milk-alkali syndrome: hypercalcemia, alkalosis, and azotemia following calcium carbonate and milk therapy of peptic ulcer. Gastroenterol 1957;33:745-69.
14. Randall RE Jr, Strauss M, McNeely WF. The milk-alkali syndrome. Arch Intern Med 1961;107:163-81.
15. McMillan DE, Freeman RB. The milk-alkali syndrome: a study of the acute disorder with comments on the development of the chronic condition. Medicine 1964;44:484-501.
16. Shuman CA, Jones HW. The "milk-alkali" syndrome: two case reports with discussion of pathogenesis. Q J Med 1985;55:119-26.
17. Jamieson MJ. Hypercalcemia. Br Med J 1985;290:378-82.
18. Orwoll EC. The milk-alkali syndrome: current concepts. Ann Intern Med 1982;97:242-48.
19. Beall DP, Scofield RH. Milk alkali syndrome associated with calcium carbonate consumption: report of 7 patients with parathyroid hormone levels and an estimate of prevalence among patients hospitalized with hypercalcemia. Medicine 1995;74:89-96.
20. Wu KD, Chuang RB, Wu FL, et al. The milk-alkali syndrome caused by betelnuts in oyster shell paste. J Toxicol Clin Toxicol 1996;34:741-45.
21. Abreo K, Adlakha A, Kilpatrick S, et al. The milk-alkali syndrome: a reversible form of acute renal failure. Arch Intern Med 1993;153:1005-10.
22. Newmark K, Nugent P. Milk-alkali syndrome: a consequence of chronic antacid abuse. Postgrad Med J 1993;93:149-56.
23. Muldowney W, Mazbar SA. Rolaids-yogurt syndrome: a 1990's version of milk alkali syndrome. Am J Kidney Dis 1996;27:270-72.
24. Carroll PR, Clark OH. Milk-alkali syndrome: does it exist and can it be differentiated from primary hyperparathyroidism? Ann Surg 1983;197:427-33.
25. Bullimore DW, Miloszewski KJ. Raised parathyroid hormone levels in the milk-alkali syndrome: an appropriate response? Postgrad Med J 1987;63:789-92.
26. Dorsch TR. The milk-alkali syndrome, vitamin D, and parathyroid hormone. Ann Intern Med 1986;105:800-01.
27. Duthie JS, Solanki HP, Krishnamurthy M, et al. Milk alkali syndrome with metastatic calcification. Am J Med 1995;99:102-3.
28. George S, Clark JDA. Milk alkali syndrome: an unusual syndrome causing an unusual complication. Postgrad Med J 2000;76:422-3.
29. Morton A. Milk-alkali syndrome in pregnancy, associated with elevated levels of parathyroid hormone-related protein [letter]. Intern Med J 2002;32:492-6.
30. Vanpee D, Delgrange E, Gillet JB, Donckier. Ingestion of antacid tablets (Rennie®) and acute confusion. J Emerg Med 2000;19:169-71.
31. Canning G, Slater SD. Failure to diagnose the milk-alkali syndrome. Scot Med J 1987;32:57-9.
32. Kleinman GE, Rodriquez H, Good MC, Caudle MR. Hypercalcemic crisis in pregnancy associated with excessive ingestion of calcium carbonate antacid (milk-alkali syndrome): successful treatment with hemodialysis. Obstr Gynecol 1990;78:496-8.
33. Ullian ME, Linas SL. The milk-alkali syndrome in pregnancy. Min Elec Metab 1988;14:208-10.
34. Kallner G, Karlsson H. Recurrent factitious hypercalcemia. Am J Med 1987;82:536-8.
35. Jenskins JK, Best TR, Nicks SA, et al. Milk-alkali syndrome with a serum calcium level of 22 mg/dl and J waves on the ECG. South Med J 1987;80:1444-9.
36. Brandwein SL, Sigman KM. Case report: milk-alkali syndrome and pancreatitis. Am J Med Sci 1994;308:173-6.
37. Tal A, Powers K. Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism. J Natl Med Assoc 1996;88:313-4.
38. Fiorino AS. Hypercalcemia and alkalosis due to the milk-alkali syndrome: a case report and review. Yale J Biol Med 1996;69:517-23.
39. Camidge R, Peaston R. Recommended dose antacid and severe hypercalcemia. Br J Clin Pharmacol 2000;52:341-2.
40. Gibbs CJ, Lee HA. Milk-alkali syndrome due to Cavad-S. J Roy Soc Med 1992;85:498-9.
41. Lin S-H, Lin Y-F, Shieh S-D. Milk-alkali syndrome in an aged patient with osteoporosis and fractures. Nephron 1996;73:496-7.
42. Lui SW, Kumar AM, Nadel ES, Brown DFM. Case presentations of the Harvard emergency medicine residency. J Emerg Med 2002;22:405-8.
43. Nakanishi T, Uyama O, Yamada T, et al. Sustained metabolic alkalosis associated with development of the milk-akali syndrome. Nepron 1992;60:251.
44. Robertson WC. Calcium carbonate consumption during pregnancy: an unusual cause of neonatal hypoclacemia. J Child Neurol 2002;17:853-5.
45. Spital A, Freedman Z. Vignette in clinical pathophysiology: severe hypercalcemia in a woman with renal failure. Am J Kidney Dis 1995;26:674-7.
46. Sulkin T, Krentz AJ. Iatrogenic recurrent severe hypercalcemia and renal impairment. Postgrad Med J 2000;76:800-7.
47. Chaudhry MU. Milk-alkali syndrome. J Arkansas Med Soc 2004;101:84-5.
48. Morton A. Milk-alkali syndrome in pregnancy, associated with elevated levels of parathyroid hormone-related protein. Intern Med J 2002;32:492-3.
49. McGuinness B, Logan JI. Milk alkali syndrome. Ulster Med J 2002;71:132-5.
50. Kallmeyer JC, Funston MR. The milk-alkali syndrome: a case report. S African Med J 1983;64:287-8.
51. Roberts RW, Tuthill SW. Milk-alkali syndrome: unusual today but not forgotten. J Louisiana State Med Soc 1984;136:42-3.
52. Schuman CA, Jones HW 3rd. The 'milk-alkali' syndrome: two case reports with discussion of pathogenesis. Q J Med 1985;55:119-26.
53. French JK, Holdaway IM, Williams LC. Milk alkali syndrome following over-the-counter antacid self-medication. N Zeal Med J 1986;99:322-3.
54. Kapsner P, Langsdorf L, Marcus R, et al. Milk-alkali syndrome in patients treated with calcium carbonate after cardiac transplantation. Arch Intern Med 1986;146:1965-8.
55. Gora ML, Seth SK, Bay WH, et al. Milk-alkali syndrome associated with use of chlorothiazide and calcium carbonate. Clin Pharm 1989;8:227-9.
56. Prince RL, Smith M, Dick IM, et al. Prevention of post-menopausal osteoporosis. N Engl J Med 1991;325:1189-95.
57. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
58. Carr CJ, Shangraw RF. Nutritional and pharmaceutical aspects of calcium supplementation. Am Pharmacol 1987;NS27:55.
59. Recker RR, Bammi A, Barger-Lux J, et al. Calcium absorbability from milk products, an imitation milk, and calcium carbonate. Am J Clin Nutr 1988;47:93-5.
60. Barreras RF, Donaldson RM Jr. Role of calcium in gastric hypersecretion, parathyroid adenoma and peptic ulcer. N Engl J Med 1967;276:1122-4.
61. Greaves I, Grant AJ, Heath DA, et al. Hypercalcemia: changing causes over the past 10 years. BMJ 1992;304:1284.
62. Malluche H, Faugere MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990;339:193-211.
63. Field MJ, Lawrence JR. Complications of thiazide diuretic therapy: an update. Med J Aust 1986;144:641-644.
64. Stiel JN, Mitchell CA, Radcliff FJ, Piper DW. Hypercalcemia in patients with peptic ulceration receiving large doses of calcium carbonate. Gastroenterol 1967;53:900-4.
65. Wilder WT, Frame B, Haubrich WS. Peptic ulcer in primary hyperparathyroidism: an analysis of fifty-two cases. Ann Intern Med 1961;55:885-93.
66. Nelson BS, Heischober B. Betel nut: a common drug used by naturalized citizens from India, Far East Asia, and the South Pacific Islands. Ann Emerg Med 1999;34:238-43.
67. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364-67.
68. Blind E, Schmidt-Gayk H, Armbruster FP, et al. Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay. Clin Chem 1987;33:1376-81.
69. Raisz LG, Yajnik CH, Bockman RS, et al. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcemia due to primary hyperparathyroidism or malignancy. Ann Intern Med 1979;91:739-40.
70. Fischer JA, Blum JW, Born W, et al. Regulation of parathyroid hormone secretion in vitro and in vivo. Calcif Tissue Int 1982;34:313-6.
71. Arnaud CD, Goldsmith RS, Bordier PJ, et al. Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man. Am J Med 1974;56:785-90.
72. Endres DB, Villanueva R, Sharp CF, et al. Measurement of parathyroid hormone. Endocr Metab Clin North Am 1989;18:611-3.
73. Ashby JP, Thakkar H. Over- and underestimation of monoclonal gammopathies by quantification of kappa- and lambda-containing immunoglobulins in serum. Am Clin Biochem 1988;25:275-9.
74. Armitage EK. Parathyrin (parathyroid hormone): metabolism and methods for assay. Clin Chem 1986;32:418-24.
75. 3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab 1979;48:1008-16.
76. Broadus AE, Insogna KL, Lang R, et al. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 1984;311:73-80.
77. Campbell SB, Macfarlane DJ, Flemming SJ, et al. Increased skeletal uptake of Tc-99m methylene diphosphonate in milk-alkali syndrome. Clin Nuc Med 1994;19:207-11.
78. Lemann J Jr, Adams ND, Gray RW. Urinary calcium excretion in human beings. N Engl J Med 1979;301:535-41.
79. Norman AW. Vitamin D metabolism and calcium absorption. Am J Med 1979;67:989-98.
80. Zerwekh JE. Vitamin D-dependent intestinal calcium absorption. Gastroenterol 1979;76:404-11.
81. Norman DA, Fordtran JS, Brinkley W, et al. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25 dihydroxy (+) vitamin D. J Clin Invest 1981;67:1599-1603.
82. Knapp EL. Factors influencing the urinary excretions of calcium in normal persons. J Clin Invest 1947;26:182-202.
83. Peacock M, Hodgkinson A, Nordin BEC. Importance of dietary calcium in the definition of hypercalciuria. Br Med J 1967;3:469-71.
84. Vincent PC, Radcliff FJ. The effect of large doses of calcium carbonate on serum and urinary calcium. Am J Dig Dis 1966;11:286-95.
85. Ivanovich P, Fellows H, Rich C. The absorption of calcium carbonate. Ann Intern Med 1967;66:917-23.
86. Epstein S, Van Mieghem W, Sagel J, et al. Effect of single large doses of oral calcium on serum calcium levels in the young and the elderly. Metab 1973;22:1163-73.
87. Massry SG. Effects of electrolyte disorders on the kidney. In: Earley LE, Bottschalk CW, editors. Strauss and Welt's Diseases of the Kidney, 3rd ed, Vol 2. Boston: Little, Brown and Company; 1979, p 1403-30.
88. Sutton RAL, Diks JH. Renal handling of calcium, phosphate, and magnesium metabolism. In: Brenner BM, Rector FC Jr, editors: The Kidney, 2nd ed, Vol. 1. Philadelphia: W.B. Saunders; 1981, p 551-618.
89. Benabe JE, Martinez-Maldonado M. Hypercalcemic nephropathy. Arch Intern Med 1978;138:7777-79.
90. Human HD, Ichikawa I, Troy JL, et al. Evidence for a parathyroid hormone-dependent influence of calcium on the glomerular ultrafiltration coefficient. J Clin Invest 1978;61:32-10.
91. Ganote CE, Philipsborn DS, Chen E, et al. Acute calcium nephrotoxicity: an electron microscopical and semi-quantitative light microscopical study. Arch Pathol Lab Med 1975;99:650-7.
92. Wong NLM, Sutton RAL, Quamme GA, et al. The effect of alkalosis on renal tubular calcium reabsorption in the dog. Clin Res 1976;24:687A.
93. Martin HE, Jones R. The effect of ammonium chloride and sodium bicarbonate on the urinary excretion of magnesium, calcium, and phosphate. Am Heart J 1961;62:206-10.
94. Parfitt AM, Higgins BA, Nassim JR, et al. Metabolic studies in patients with hypercalciuria. Clin Sci 1964;27:463-82.
95. Transbol I, Hahnemann S, Hornum I. The tubular reabsorption of calcium in primary hyperparathyroidism and in non-parathyroid hypercalcemia. Acta Med Scand 1968;184:33-43.
96. Seldin DW, Rector FC Jr. The generation and maintenance of metabolic alkalosis. Kidney Int 1972;1:306-21.
97. Gill JR Jr, Bartter FC. On the impairment of renal concentrating ability in prolonged hypercalcemia and hypercalciuria in man. J Clin Invest 1961;40:716-22.
98. Beck N, Singh H, Reed SW, et al. Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia. J Clin Invest 1974;54:1049-55.
99. Saki WT, Eknoyan G, Rector FC, et al. The renal diluting and concentrating mechanism in hypercalcemia. Nephron 1969;6:50-61.
100. Levitt MF, Halpern MH, Polimeros DP, et al. The effect of abrupt changes in plasma calcium concentrations on renal function and electrolyte excretion in man and monkey. J Clin Invest 1958;37:294-305.
101. Morris RC Jr, Sebastian A, McSherry E. Renal acidosis. Kidney Int 1972;1:322-10.
102. Muldowney FP, Donohoe JF, Freaney R, et al. Parathormone-induced renal bicarbonate wastage in intestinal malabsorption and in chronic renal failure. Ir J Med Sci 1970;3:221-31.
103. Crumb CK, Martinez-Maldonada M, Eknoyan G, et al. Effects of volume expansion, purified parathyroid extract, and calcium or renal bicarbonate absorption in the dog. J Clin Invest 1974;54:1287-94.
104. Muldowney FP, Carroll DV, Donohoe JF, et al. Correction of renal bicarbonate wastage by parathyroidectomy: implications in acid-base hemostasis. Q J Med 1971;40:487-98.
105. Palmer FJ, Nelson JC, Bacchus H. The chloride-phosphate ratio in hypercalcemia. Ann Intern Med 1974;80:200-4.
106. Kurtzman NA, Arruda AL. Hypoparathyroidism and metabolic acidosis: a complex interaction of multiple factors. Nephron 1980;26:1-3.
107. Parfitt AM, Kleerekoper M. The divalent ion homeostatic system: physiology and metabolism of calcium, phosphorus, magnesium, and bone. In: Maxwell MH, Kleeman CR. editors. Clinical Disorders of Fluid and Electrolyte Metabolism, 3rd ed. New York: McGraw-Hill; 1980; p 269-398.
108. Gough J, Duguid JB, Davies DR. The renal lesions in hypervitaminosis D: observations on the urinary calcium and phosphorus excretion. Br J Exp Pathol 1933;14:137-45.
109. Parfitt AM. Soft-tissue calcification in uremia. Arch Intern Med 1969;124:544-6.
110. Sanderson PH. Renal response to massive alkali loading in the human subject. In: Ciba Foundation Symposium on the Kidney. Boston: Little, Brown and Company; 1954, p 165-76.
111. Van Goidsenhoven GM-T, Gray OV, Price AV, et al. The effect of prolonged administration of large doses of sodium bicarbonate in man. Clin Sci 1954;13:383-401.
112. Maggio AJ Jr, Coburn JW, Brosman SA, et al. The role of vitamin D in idiopathic hypercalciuria. J Urol 1979;122:17-151.
113. Masry SG, Friedler RM, Coburn JN. Excretion of phosphate and calcium: physiology of their renal handling and relation to clinical medicine. Arch Intern Med 1973;131:828-58.
114. Frame B, Parfitt AM. Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25-dihydroxyvitamin D. Ann Intern Med 1980;93:449-51.
115. Schaefer PC, Fadem SZ, Lifschitz M, et al. Hypercalcemia due to high serum 1-alpha, 25-dihydroxycholecalciferol (1,25-DHCC). Clin Res 1978;26:533A.
116. Pikolos MK, Lavis VR, Orlander PR. Milk-alkali syndrome is a major cause of hypercalcemia among non-end-stage renal disease inpatients. Clin Endocrinal 2005;63:566-76.